Esperion Therapeutics Inc (OQ:ESPR)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for ESPR within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET November 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Nov 8/19 Nov 6/19 Mayleben Timothy M Direct Ownership Common Stock P - Open market or private purchase 5,000 $36.98
Nov 8/19 Nov 6/19 Biotech Target N V Direct Ownership Common Stock P - Open market or private purchase 75,000 $37.30
Sep 6/19 Sep 6/19 Mayleben Timothy M Direct Ownership Common Stock P - Open market or private purchase 2,500 $35.25
Sep 6/19 Sep 4/19 Mayleben Timothy M Direct Ownership Common Stock P - Open market or private purchase 148 $33.42
Sep 6/19 Sep 4/19 Mayleben Timothy M Direct Ownership Common Stock P - Open market or private purchase 4,852 $34.22
Sep 6/19 Sep 4/19 Biotech Target N V Direct Ownership Common Stock P - Open market or private purchase 80,000 $33.78
Aug 2/19 Aug 1/19 Mayleben Timothy M Direct Ownership Common Stock P - Open market or private purchase 5,000 $39.56
Jul 25/19 Jul 23/19 Biotech Target N V Direct Ownership Common Stock P - Open market or private purchase 50,000 $42.65
Jul 1/19 Jun 28/19 Mayleben Timothy M Direct Ownership Common Stock P - Open market or private purchase 5,000 $46.00
Apr 5/19 Apr 3/19 Bartram Richard Direct Ownership Common Stock S - Open market or private sale 1,500 $43.62
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ESPR within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET November 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Nov 8/19 Nov 6/19 Mayleben Timothy M Direct Ownership Common Stock P - Open market or private purchase 5,000 $36.98
Nov 8/19 Nov 6/19 Biotech Target N V Direct Ownership Common Stock P - Open market or private purchase 75,000 $37.30
Sep 6/19 Sep 6/19 Mayleben Timothy M Direct Ownership Common Stock P - Open market or private purchase 2,500 $35.25
Sep 6/19 Sep 4/19 Mayleben Timothy M Direct Ownership Common Stock P - Open market or private purchase 148 $33.42
Sep 6/19 Sep 4/19 Mayleben Timothy M Direct Ownership Common Stock P - Open market or private purchase 4,852 $34.22
Sep 6/19 Sep 4/19 Biotech Target N V Direct Ownership Common Stock P - Open market or private purchase 80,000 $33.78
Aug 2/19 Aug 1/19 Mayleben Timothy M Direct Ownership Common Stock P - Open market or private purchase 5,000 $39.56
Jul 25/19 Jul 23/19 Biotech Target N V Direct Ownership Common Stock P - Open market or private purchase 50,000 $42.65
Jul 1/19 Jun 28/19 Mayleben Timothy M Direct Ownership Common Stock P - Open market or private purchase 5,000 $46.00
Apr 5/19 Apr 3/19 Bartram Richard Direct Ownership Common Stock S - Open market or private sale 1,500 $43.62
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $ESPR

StockTwits